Patent directory · USPTO A61K / A61P
Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”
783 pharma patents match "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 783 pharmaceutical patents matching "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9993660
Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial infections
granted -
US 9976130
OPAA FL—a mutant enzyme with increased catalytic efficiency on organophosphorus compound GD
granted -
US 9968669
Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome
granted -
US 9957486
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
granted -
US 9951353
Engineering neural stem cells using homologous recombination
granted -
US 9944918
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)
granted -
US 9944951
Chromosome 3p21.3 genes are tumor suppressors
granted -
US 9938526
Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
granted -
US 9919040
Soluble recombinant plasmodium falciparum circumsporozoite protein, use in vaccines, methods of making and uses thereof
granted -
US 9913892
Materials and methods for respiratory disease control in canines
granted -
US 9896484
Influenza virus recombinant proteins
granted -
US 9896511
Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
granted -
US 9884100
Lutzomyia longipalpis polypeptides and methods of use
granted -
US 9873893
Methods and compositions for treating genetically linked diseases of the eye
granted -
US 9861681
Therapeutic compositions for neutralizing type I interferons, and methods of use
granted -
US 9833437
Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure
granted -
US 9833468
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
granted -
US 9809643
Identification of antibodies specific for at least two different lyssaviruses
granted -
US 9801865
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation
granted -
US 9789162
Systemic and local ex vivo gene therapy of the skeleton
granted -
US 9783579
Compositions and methods for dengue virus chimeric constructs in vaccines
granted -
US 9783596
Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use
granted -
US 9783590
Variants of human taste receptor genes
granted -
US 9770405
Biocompatible capsules and methods of making
granted